tirzepatide vs semaglutide efficacy weight loss diabetes of and in reducing liver fat A 72-week trial compared the two leading GLP-1 medications adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% ✓ Semaglutide Cardiovascular outcomes of semaglutide and
Pay in 4 interest-free payments of $7.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




















